PMID: 9443044Jan 27, 1998Paper

Clinical aspects of aplastic anemia

Hematology/oncology Clinics of North America
E C Guinan

Abstract

Severe aplastic anemia is a disorder characterized by peripheral pancytopenia and marrow hypoplasia. Although its pathophysiology is understood poorly, the majority of patients appear to have some immunologic destruction or suppression of hematopoietic cells. The only curative therapy to date is allogeneic stem cell transplantation, although the success of palliative immunosuppressive therapies has improved over the last two decades. Making the best therapy choice is complex and often requires balancing very divergent toxicity profiles, both acute and long-term.

References

Mar 1, 1979·British Journal of Haematology·M Van HengstumC Haanen
Jan 6, 1977·The New England Journal of Medicine·R HoffmanL R Wasserman
Jun 1, 1989·British Journal of Haematology·E M LeonardN S Young
Jul 1, 1988·British Journal of Haematology·A TichelliB Speck
Jun 1, 1988·International Journal of Radiation Oncology, Biology, Physics·B ShankR J O'Reilly
Jul 1, 1985·The American Journal of Medicine·R F HunterA T Huang
Sep 1, 1983·British Journal of Haematology·W J MillerH S Jacob
Mar 8, 1984·The New England Journal of Medicine·P A StryckmansL Debusscher
Jun 14, 1984·The New England Journal of Medicine·A BacigalupoM T Van Lint
Sep 1, 1983·British Journal of Haematology·S M FairheadE C Gordon-Smith
Mar 4, 1993·The New England Journal of Medicine·N A KernanJ McCullough

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.